Philadelphia’s Talent Pipeline Collaborative Readies Region For Cell And Gene Therapy Job Growth

Claire Greenwood, Executive Director, CEO Council for Growth, and Patricia Day, Manager, Leadership Engagement, the Chamber of Commerce for Greater Philadelphia elaborate on the creation of the Life Science Talent Pipeline Collaborative in an op-ed originally published at CellandGene.com.

Region’s Reputation for Cell & Gene Therapy Grew in 2020

The Greater Philadelphia region’s reputation as a center for the cell and gene therapy industry grew in 2020 as breakthrough research from industry academia pioneers is increasingly complemented by strong capital investment and real estate projects meeting the specialized land, building, and lab development needs of start-up, scaling and relocating companies.

Investment

According to research from biopharma database company DealForma (as of December 9, 2020), the Greater Philadelphia region saw 49 life sciences investment deals in 2020, valued at more than $12 billion, including six in the cell and gene therapy space totaling $4.5 billion. Among the cell and gene therapy investment […]

Research, Investment, Real Estate Development, and Job Growth Predictions Drive Greater Philadelphia’s Reputation as a Leading Cell & Gene Therapy Hub: 2020 In Review

PHILADELPHIA (December 17, 2020) – The Greater Philadelphia region’s reputation as a center for the cell and gene therapy and connected health industries grew in 2020, driven by breakthrough research from  industry pioneers, strong capital investment, and real estate projects meeting specialized land, building, and lab development needs for start-up, scaling and relocating companies. Further evidence of the momentum comes from a workforce talent study announced this year that predicts strong growth over the coming decade for the sectors.

According to research from biopharma database company DealForma (as of December 9, 2020), the Greater Philadelphia region saw 49 life sciences investment […]

COVID-19 Research Contributions from Partners in Greater Philadelphia’s Cell & Gene Therapy and Connected Health Initiative Impact Global Health

Partners in Greater Philadelphia’s Cell & Gene Therapy and Connected Health Initiative continue to make significant contributions to the response to SARS-CoV-2, impacting human health not just regionally, but globally as well.  The Chamber of Commerce for Greater Philadelphia’s regional CEO Council for Growth has compiled a list of just some of the recent research and development contributions made by its partners in the Initiative. The round-up includes research updates from Penn Medicine on vaccine development; Children’s Hospital of Philadelphia on COVID-19 tracking; ChristianaCare on gene editing; and Aramark on the creation of a workplace safety digital product.

Penn Medicine

Penn Medicine […]

Go to Top